News
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
(Reuters) -The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus ...
Hosted on MSN3m
FDA expands Moderna's RSV vaccine approval to at-risk adultsThe U.S. Food and Drug Administration has approved Moderna’s (NASDAQ:MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing ...
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...
Cambridge: Moderna, Inc. has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for ...
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
Health Secretary Robert F. Kennedy Jr. announced a slate of eight new members to serve on the Advisory Committee on ...
Moderna said the Food and Drug Administration expanded its approval of the pharmaceutical company's respiratory syncytial virus vaccine, mResvia, to adults aged 18-59 at increased risk for the disease ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the ...
StockStory.org on MSN6h
3 Healthcare Stocks with Questionable FundamentalsPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
Daniel Suárez se ha convertido en el guía turístico no oficial de todo lo relacionado con la Ciudad de México mientras NASCAR ...
Interest in what caused the coronavirus pandemic has many political dimensions today, with President Trump saying genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results